A prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study

Makito Miyake, Nobumichi Tanaka, Isao Asakawa, Kaori Yamaki, Takashi Inoue, Shota Suzuki, Shunta Hori, Yasushi Nakai, Satoshi Anai, Kazumasa Torimoto, Michihiro Toritsuka, Hitoshi Nakagawa, Shinji Tsukamoto, Tomomi Fujii, Chiho Ohbayashi, Masatoshi Hasegawa, Masato Kasahara, Kiyohide Fujimoto